Log in
Enquire now
VerImmune

VerImmune

VerImmune is an Immuno-Oncology company developing a first-in-class cancer therapy known as Anti-tumor Immune Redirection.

OverviewStructured DataIssuesContributors

Contents

verimmune.com
Is a
Company
Company
Organization
Organization

Company attributes

Industry
Biotechnology
Biotechnology
Health technology
Health technology
Location
United States
United States
Baltimore
Baltimore
B2X
B2B
B2B
CEO
‌
Joshua Weiyuan Wang
0
Pitchbook URL
pitchbook.com/profiles...466441-48
Number of Employees (Ranges)
1 – 10
Email Address
info@verimmune.com
Phone Number
+14434498836
Full Address
1812 ASHLAND AVENUE SUITE 100 BALTIMORE, MD 21205
CIK Number
1,903,915
Investors
Ulu Ventures
Ulu Ventures
0
Gaingels
Gaingels
Mana Ventures
Mana Ventures
Proxima Ventures
Proxima Ventures
Founded Date
2020
Total Funding Amount (USD)
7,000,000
Latest Funding Round Date
September 23, 2024
Latest Funding Type
Seed
Seed
Patents Assigned (Count)
1

Other attributes

Latest Funding Round Amount (USD)
4,500,000
No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like VerImmune

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.